ClinicalTrials.gov
ClinicalTrials.gov Menu

TIII Over TI in Subjects With Myocardial Infarction (T-infarction)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03057093
Recruitment Status : Completed
First Posted : February 17, 2017
Last Update Posted : February 17, 2017
Sponsor:
Information provided by (Responsible Party):
Dr. Fikret Er, University Hospital Muenster

Brief Summary:
Study was performed to identify ECG criteria for unmasking of subjects with NSTEMI at elevated risk.

Condition or disease Intervention/treatment
NSTEMI - Non-ST Segment Elevation MI Other: Non interventional study

Detailed Description:
In the present study the investigators assessed the value of T wave changes in subjects with NSTEMI (TIII>TI).

Study Type : Observational
Actual Enrollment : 903 participants
Observational Model: Case-Control
Time Perspective: Retrospective
Official Title: Assessment of T Wave Changes of Patients With Acute Non-ST-elevation Myocardial Infarction
Actual Study Start Date : January 1, 2011
Actual Primary Completion Date : September 30, 2013
Actual Study Completion Date : January 15, 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Attack

Group/Cohort Intervention/treatment
TIII>TI
Subjects with TIII>TI in initial ECG
Other: Non interventional study
retrospective noninterventional study

Non TIII>TI
Subjects without TIII>TI in initial ECG
Other: Non interventional study
retrospective noninterventional study




Primary Outcome Measures :
  1. Myocardial infarction size [ Time Frame: 5 Days ]
    Assessment of myocardial damage using biomarkers


Secondary Outcome Measures :
  1. Correlation with coronary artery [ Time Frame: 1 day ]
    Assessment of association of infarct related artery and ECG changes



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Sampling Method:   Non-Probability Sample
Study Population
Subjects with acute myocardial infarction without ST segment elevation
Criteria

Inclusion Criteria:

  • NSTEMI and PCI

Exclusion Criteria:

  • NSTEMI without percutaneous intervention

Responsible Party: Dr. Fikret Er, Head of the department, University Hospital Muenster
ClinicalTrials.gov Identifier: NCT03057093     History of Changes
Other Study ID Numbers: Twave1
First Posted: February 17, 2017    Key Record Dates
Last Update Posted: February 17, 2017
Last Verified: February 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Dr. Fikret Er, University Hospital Muenster:
NSTEMI, ECG

Additional relevant MeSH terms:
Infarction
Myocardial Infarction
Non-ST Elevated Myocardial Infarction
Ischemia
Pathologic Processes
Necrosis
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases